Phil Tennant sold $594K of Precigen (PGEN)

Executed Aug 25, disclosed Aug 25, the same day.

Value, as filed

$594K

79,166 sh × $7.50

Executed

Aug 25

the trade date, as filed

Disclosed

Aug 25

0 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Phil Tennant Chief Commercial Officer profile →

Phil Tennant (Chief Commercial Officer) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Precigen, Inc. (PGEN). The largest single filing was $594K of PGEN (79,166 sh × $7.50, as filed), executed Aug 25.

The name

PGEN

Precigen, Inc. PGEN · Healthcare · 21 filings in 24 months ticker →

Healthcare · Precigen, Inc.,a discovery and clinical-stage biopharmaceutical company, develops gene and cell therapies using precision technology to tar…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Phil Tennant in PGEN

PGENSALE Precigen, Inc. $132K
30,272 sh × $4.36
Exec May 28
Filed Jun 1 · 5:30 PM ET